Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Scientists at UC San Francisco have pioneered a groundbreaking approach to fighting cancer using engineered fat cells. By ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Immune checkpoint inhibitors boost the immune ... This would either cause the cancer cells to die off or prevent them from growing. CRISPR is an example of gene editing that lets researchers ...

And we’ve also made additional edits using the CRISPR system that makes them autologous ... except for one-off patients that may be immune -- that may not have an immune system that’s competent.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...